Aurora Cannabis Gains Coming Coming. Here is what to expect.

Text size

Aurora Cannabis

should release its third quarter results after the closing bell Tuesday.

Wall Street expects a loss of 3 cents per share on a $ 55.1 million business figure, according to Zacks Equity Research.

The stock of the Canadian-based producer (symbol: ACB) increased 70% in 2019 and 33.6% from the previous year, compared to a gain of 15% in
S & P 500
in 2019 and a gain of 5.6% over the previous year. The Aurora stock closed up 0.12% to $ 8.36 on Friday.

Here is an overview of Wall Street's expectations and recent history.

• Despite its size, Aurora has not yet contracted to receive an investment from a major US company. This has brought activist Nelson Peltz as a "strategic advisor" to help change that. Shares climbed in March during the announcement.

• Several Canadian marijuana stocks disappeared in April after Cowen analyst Vivien Azer these producers could be affected by an accumulation of "substandard" cannabis that is not salable. She noted that slowing the pace of retail rollout, particularly in Ontario, could hurt Aurora.

• A week later, Aurora received a boost after the company announced its agreement to purchase the remaining shares of Hempco Food and Fiber, which would allow Aurora to take advantage of legal hemp in the United States.

• Canadian government data showed that recreational marijuana sales in January and February were "disappointingly disappointing", the industry totals for September and October 2018.

• Despite the difficulties of the supply chain, Bank of America Merrill Lynch'sChristopher Carey Aurora insider with a purchase rating. He said expecting that an underdeveloped supply chain will continue to undermine Canadian cannabis companies, but that in this environment, his bullish stock options like Aurora may outperform.